The Centers for Medicare & Medicaid Services proposed a rule that would halt Medicare reimbursements for remote patient monitoring services administered by third-party health technology vendors.^[1] The proposed rule would apply only to traditional Medicare enrollees, not participants in privately run Medicare Advantage plans.^[2] Caroline Pearson, executive director of the Peterson Center on Healthcare, stated the proposed rule would virtually eliminate or dramatically reduce remote monitoring access for many Medicare patients, particularly those in rural areas.^[3] Medicare spending on remote physiologic monitoring grew from under $7 million in 2019 to over $194 million in 2023, per an April 2025 Peterson Center on Healthcare report.^[4] Three separate Medicare enforcement actions were reported 22 October 2026. A healthcare software company CEO was sentenced to 19 years prison for a $1 billion Medicare fraud scheme.^[5] Somerset Lifesciences will pay $4 million to resolve Medicare improper billing allegations for olopatadine eye drops.^[6] Steven Powell, MD, former New Hampshire hospital CMO, was sentenced to over 1 year prison for a $1.9 million Medicare billing scheme.^[7]